(Q39434507)

English

Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

substance dependence

0 references

1 reference

based on heuristic

inferred from title

Tetsuya Mitsudomi

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yoshihiko Maehara

4

object named as

Yoshihiko Maehara

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

5

object named as

Yasushi Yatabe

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

3

object named as

Hirotaka Osada

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yoshitaka Sekido

6

object named as

Yoshitaka Sekido

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1

object named as

Kenichi Suda

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Kenji Tomizawa

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

76

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

292-299

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

describes a project that uses

0 references

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Tumour biology: senescence in premalignant tumours

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/436642A

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2009.11.022

Identifiers

10.1016/J.LUNGCAN.2011.11.007

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39434507&oldid=1835173930"